| # | Compound | Evidence | EU Status | Last reviewed |
|---|---|---|---|---|
| 001. | SS-31 INN · elamipretidum Cell-permeable tetrapeptide · cardiolipin-binding · mitochondrial-targeted | B | NOT AUTHORISED | 18 MAY 2026 |
| 002. | Epitalon C₁₄H₂₂N₄O₉ · MW 390.4 Synthetic tetrapeptide · claimed pineal regulator and telomerase activator | D | NOT AUTHORISED | 18 MAY 2026 |
| 003. | FOX04-DRI D-retro-inverso peptide · disrupts FOXO4-p53 interaction · senolytic | D | NOT AUTHORISED | 18 MAY 2026 |
| 004. | Humanin Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala 24-AA mitochondrial-derived peptide · cytoprotective signalling | D | NOT AUTHORISED | 18 MAY 2026 |
| 005. | Livagen Lys-Glu-Asp-Ala Tetrapeptide bioregulator · claimed hepatic tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 006. | MOTS-c Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg 16-AA mitochondrial-derived peptide · metabolic regulator (AMPK pathway) | D | NOT AUTHORISED | 18 MAY 2026 |
| 007. | Vilon Lys-Glu Dipeptide bioregulator · claimed thymic / immune modulator | D | NOT AUTHORISED | 18 MAY 2026 |